Over 14,000 women took Sanofi epilepsy drug despite fetus risk: ministry

PARIS (Reuters) - More than 14,000 pregnant women in France took Sanofi's anti-epilepsy drug Depakine between 2007 and 2014 even though the risk of fetus malformation was known, according to a study released by France on Wednesday.